-transparent.png){kind=logo}
Twelve patients chronically maintained on warfarin were administered 80 mg atorvastatin for 2 weeks. Mean prothrombin times decreased slightly, but only for the first few days of the two-week treatment period. Thus atorvastatin had no consistent effect on the anticoagulant activity of warfarin and adjustment in warfarin dosing should not be necessary.
Related Publications
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
January 1992,
Epilepsia,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
January 1993,
European journal of clinical pharmacology,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
September 2015,
Pakistan journal of pharmaceutical sciences,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
February 1998,
European journal of clinical pharmacology,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
August 1990,
Journal of clinical pharmacology,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
December 1990,
La Clinica terapeutica,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
January 2014,
International scholarly research notices,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
January 1992,
Clinical pharmacokinetics,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
May 2008,
Clinical and experimental immunology,
R Stern, and
R Abel, and
G L Gibson, and
J Besserer
November 1985,
Antimicrobial agents and chemotherapy,
